BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12623188)

  • 1. The influence of drug type on the release profiles from Surelease-coated pellets.
    Sadeghi F; Ford JL; Rajabi-Siahboomi A
    Int J Pharm; 2003 Mar; 254(2):123-35. PubMed ID: 12623188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of drug release from pellets coated with HPMC or Surelease.
    Sadeghi F; Ford JL; Rubinstein MH; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2000 Jun; 26(6):651-60. PubMed ID: 10826113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of drug release from pellets coated with Surelease containing hydroxypropylmethylcellulose.
    Sadeghi F; Ford JL; Rubinstein MH; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2001 May; 27(5):419-30. PubMed ID: 11448049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of Surelease and sodium alginate on the in-vitro release of tamsulosin hydrochloride in pellet dosage form.
    Kim MS; Jun SW; Lee S; Lee TW; Park JS; Hwang SJ
    J Pharm Pharmacol; 2005 Jun; 57(6):735-42. PubMed ID: 15969928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of polymeric dispersion type on the release of diclofenac sodium from coated pellets].
    Krejcová K; Rabisková M; Vetchý D; Tomásek V; Prokopová A
    Ceska Slov Farm; 2007 Jul; 56(4):190-9. PubMed ID: 17969318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Film-coated matrix mini-tablets for the extended release of a water-soluble drug.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2015 Apr; 41(4):623-30. PubMed ID: 24564797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the release mechanism of Theophylline from pellets coated with Surelease
    Kazlauske J; Cafaro MM; Caccavo D; Marucci M; Lamberti G; Barba AA; Larsson A
    Int J Pharm; 2017 Aug; 528(1-2):345-353. PubMed ID: 28583332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of water soluble additives and HPMCP on drug release from Surelease-coated pellets containing tamsulosin hydrochloride.
    Kim MS; Kim JS; Kang SH; Yoo YH; Lee S; Park JS; Woo JS; Hwang SJ
    Arch Pharm Res; 2007 Aug; 30(8):1008-13. PubMed ID: 17879755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of sodium alginate on physical and dissolution properties of Surelease-matrix pellets prepared by a novel pelletizer.
    Kim MS; Kim JS; Hwang SJ
    Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1631-4. PubMed ID: 17978525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of the treatment conditions on the dissolution profile of ethylcellulose coated pellets.
    Pavloková S; Muselík J; Sabadková D; Bernatová S; Samek O; Neumann D; Franc A
    Eur J Pharm Sci; 2019 Apr; 132():86-95. PubMed ID: 30825510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.
    Liu Y; Sun Y; Sun J; Zhao N; Sun M; He Z
    Int J Pharm; 2012 Apr; 426(1-2):21-28. PubMed ID: 22266529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.
    Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang
    PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of processing and curing conditions on beads coated with an aqueous dispersion of cellulose acetate phthalate.
    Williams RO; Liu J
    Eur J Pharm Biopharm; 2000 May; 49(3):243-52. PubMed ID: 10799816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the drug release patterns and long term stability of aqueous and organic coated pellets by using blends of enteric and gastrointestinal insoluble polymers.
    Kranz H; Gutsche S
    Int J Pharm; 2009 Oct; 380(1-2):112-9. PubMed ID: 19632313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and characterization of a compacted multiparticulate system for modified release of water-soluble drugs--Part II theophylline and cimetidine.
    Cantor SL; Hoag SW; Augsburger LL
    Drug Dev Ind Pharm; 2009 May; 35(5):568-82. PubMed ID: 18979306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surelease or organic solution of ethylcellulose in preparation of sustained release theophylline micromatrices or matrices using spray drying technique.
    Afrasiabi Garekani H; Sedighi S; Sadeghi F
    Pharm Dev Technol; 2015 Mar; 20(2):204-10. PubMed ID: 24286215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimised process and formulation conditions for extended release dry polymer powder-coated pellets.
    Terebesi I; Bodmeier R
    Eur J Pharm Biopharm; 2010 May; 75(1):63-70. PubMed ID: 20079833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH; Taha NF; Badr RM; Mursi NM
    Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug release from beads coated with an aqueous colloidal ethylcellulose dispersion, Aquacoat, or an organic ethylcellulose solution.
    Wesseling M; Bodmeier R
    Eur J Pharm Biopharm; 1999 Jan; 47(1):33-8. PubMed ID: 10234525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethylcellulose film coating of guaifenesin-loaded pellets: A comprehensive evaluation of the manufacturing process to prevent drug migration.
    Melegari C; Bertoni S; Genovesi A; Hughes K; Rajabi-Siahboomi AR; Passerini N; Albertini B
    Eur J Pharm Biopharm; 2016 Mar; 100():15-26. PubMed ID: 26686647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.